Ethmoid Hematoma

Progressive ethmoid hematoma is an expansile, non-neoplastic mass that originates from the ethmoid labyrinth in the caudal nasal passages of horses. Despite its name containing the word hematoma, this condition is not a simple blood clot but rather a progressive, encapsulated mass of blood products, fibrous tissue, and inflammatory debris that gradually enlarges over time. The mass arises from the highly vascular ethmoid turbinates, which are delicate scroll-like structures in the back of the nasal cavity responsible for warming and filtering inspired air. Once initiated, the lesion continues to grow slowly but persistently, eventually causing significant obstruction of the nasal passages and associated clinical signs.

This condition occurs most commonly in middle-aged to older horses, with the typical age of onset being over nine years old and the majority of cases diagnosed in horses fifteen years of age or older. There does not appear to be a significant breed predisposition, though some studies have suggested slightly higher incidence in Thoroughbreds and Arabians. The condition affects geldings, mares, and stallions with relatively equal frequency. Progressive ethmoid hematoma represents one of the most common causes of unilateral epistaxis, or nosebleeding from a single nostril, in horses, making it an important differential diagnosis for any horse presenting with this clinical sign.

The impact of progressive ethmoid hematoma on equine health depends largely on the size and location of the mass and how long it has been present before diagnosis. Small, early-stage lesions may cause only intermittent mild epistaxis with minimal effect on overall health. However, as the mass enlarges, it progressively obstructs airflow through the affected nasal passage, potentially extending into the paranasal sinuses or even crossing the nasal septum to affect both sides. Large masses can cause significant respiratory obstruction, chronic nasal discharge, facial deformity, and substantial discomfort for the affected horse.

Early detection and treatment of progressive ethmoid hematoma significantly improves outcomes and reduces the likelihood of recurrence. When identified and treated while still small, the condition can often be successfully managed with less invasive procedures and lower recurrence rates than large, advanced lesions. Horse owners should be aware that any unexplained epistaxis, particularly when recurring from the same nostril, warrants veterinary evaluation. With appropriate treatment, many horses with progressive ethmoid hematoma can achieve complete resolution of clinical signs, though long-term monitoring is essential due to the potential for recurrence.

The precise cause of progressive ethmoid hematoma remains incompletely understood, though the condition is believed to originate from hemorrhage within the highly vascular ethmoid turbinate mucosa. The ethmoid region contains an extensive network of blood vessels supplying the thin-walled turbinate structures, and disruption of these vessels may initiate the cascade leading to hematoma formation. What triggers the initial hemorrhage and why the resulting lesion continues to expand progressively rather than resolving normally are questions that continue to be investigated through clinical research.

No genetic or breed predisposition has been conclusively established for progressive ethmoid hematoma, though some researchers have noted apparent increased incidence in certain breeds including Thoroughbreds, Arabians, and Warmbloods. These observations may reflect reporting bias rather than true breed susceptibility, as these breeds are often used in athletic pursuits where performance decrements and epistaxis are more likely to prompt veterinary evaluation. The condition occurs across all breeds and types of horses, including ponies and donkeys, without clear familial patterns suggesting inherited susceptibility.

Environmental and management factors that may contribute to the development of progressive ethmoid hematoma include chronic inflammation of the nasal passages from dust, allergens, or infectious agents. Horses housed in dusty environments or fed poor-quality, moldy hay may experience chronic low-grade nasal inflammation that could predispose to vascular fragility in the ethmoid region. Previous trauma to the head or nasal area has been suggested as a potential initiating factor, though direct evidence supporting this association is limited. Some cases develop without any identifiable predisposing factors.

Risk factors consistently associated with progressive ethmoid hematoma include advancing age, with the vast majority of cases occurring in horses over nine years of age. The reason for this age association is unclear but may relate to cumulative effects of chronic nasal inflammation, age-related changes in blood vessel integrity, or alterations in local tissue healing responses. No consistent associations with diet, exercise intensity, geographic location, or management system have been established. The condition appears to develop sporadically across diverse equine populations.

The pathophysiology of progressive ethmoid hematoma involves an abnormal tissue response to hemorrhage within the ethmoid mucosa. Rather than the normal sequence of clot formation, organization, and resolution, the lesion becomes encapsulated by fibrous tissue and continues to accumulate blood products, creating a progressively expanding mass. The capsule surrounding the hematoma contains numerous fragile blood vessels that bleed intermittently, contributing both to the episodic epistaxis characteristic of the condition and to continued expansion of the mass. This self-perpetuating cycle of hemorrhage, expansion, and encapsulation explains the progressive nature of the lesion.

Early warning signs of progressive ethmoid hematoma are often subtle and may go unnoticed for extended periods. The most characteristic early symptom is intermittent, mild epistaxis from a single nostril, often occurring spontaneously without relation to exercise or apparent trauma. The bleeding may be so slight that it is observed only as dried blood around the nostril or on stable walls and feed bins. Because horses are prey animals that instinctively hide signs of illness and the early bleeding is often minimal and self-limiting, owners may not recognize the significance of these initial episodes. Some horses may show occasional snorting or mild nasal discharge that goes unremarked.

The most commonly recognized symptom of progressive ethmoid hematoma is unilateral epistaxis, which becomes more frequent and severe as the mass enlarges. The bleeding episodes are typically spontaneous and not associated with exercise, helping to differentiate this condition from exercise-induced pulmonary hemorrhage. Blood may drip steadily from one nostril for minutes to hours before stopping spontaneously. The affected nostril is consistently the same, though in advanced cases where the mass has crossed the nasal septum, bilateral epistaxis may occur. The blood is typically fresh and red, distinguishing it from the darker blood that might indicate bleeding from lower respiratory sources.

Behavioral changes associated with progressive ethmoid hematoma may include head shaking, rubbing the face against objects, and apparent discomfort when the head is handled or when wearing a bridle or halter. Affected horses may resist having their faces touched or show anxiety during activities that involve pressure on the nasal area. Some horses exhibit decreased appetite if the mass has grown large enough to cause discomfort during eating, though this is less common in early stages. Respiratory noise from the affected nostril may develop as the mass enlarges and begins to obstruct airflow.

Physical signs beyond epistaxis include unilateral nasal discharge that may be serous, mucoid, or blood-tinged between active bleeding episodes. As the mass grows, it may cause visible obstruction of the nasal passage when viewed from outside or may produce audible respiratory noise during breathing. In advanced cases, facial deformity may develop as the expanding mass distorts the overlying bone and soft tissue. Extension into the paranasal sinuses can cause swelling over the affected sinus region. Halitosis may develop if secondary infection occurs within the mass or surrounding tissues.

Symptom progression follows the pattern of the enlarging mass, with early cases showing only intermittent mild epistaxis progressing to frequent, more profuse bleeding as the lesion grows. Nasal obstruction develops gradually, initially causing only subtle changes in airflow that may manifest as mild respiratory noise during exercise. With continued enlargement, respiratory obstruction becomes more pronounced, potentially affecting exercise tolerance and breathing comfort. Nasal discharge may become more purulent if secondary infection develops, and facial swelling may become apparent in advanced cases.

Emergency symptoms requiring immediate veterinary attention include profuse, uncontrollable epistaxis that does not stop spontaneously, signs of significant blood loss such as weakness, pale gums, or elevated heart rate, severe respiratory distress from nasal obstruction, or sudden development of facial swelling suggesting acute expansion or infection of the mass. While progressive ethmoid hematoma is generally a slowly progressive condition, acute hemorrhage can occasionally be severe enough to cause significant blood loss requiring emergency intervention. Any horse with repeated or unexplained epistaxis should receive veterinary evaluation even if individual episodes resolve spontaneously.

Physical examination of horses with suspected progressive ethmoid hematoma begins with careful observation of the external nasal area and assessment of airflow from each nostril. The veterinarian will note any asymmetry in nasal airflow, presence of blood or discharge, and any facial swelling or deformity that might indicate an expansile mass. External palpation of the face and paranasal sinus regions may reveal sensitivity or swelling in advanced cases. Percussion of the sinuses can sometimes detect abnormal fluid levels or tissue density changes. However, the deep location of ethmoid hematomas within the nasal passages means that external examination alone cannot confirm the diagnosis.

Endoscopic examination of the upper airway provides direct visualization of the ethmoid region and is essential for diagnosing progressive ethmoid hematoma. Using a flexible fiberoptic endoscope passed through the nostril, the veterinarian can visualize the characteristic appearance of the lesion. Ethmoid hematomas typically appear as smooth, greenish-yellow to reddish masses located in the caudal nasal passages, originating from the ethmoid turbinate region. The surface may show areas of recent hemorrhage or blood clot. The mass is usually covered by respiratory epithelium, distinguishing it from other nasal tumors that may have more irregular surfaces. The size, location, and extent of the lesion can be assessed endoscopically.

Advanced diagnostic imaging provides crucial information about the size, location, and extent of progressive ethmoid hematoma that cannot be fully appreciated through endoscopy alone. Radiographs of the head may show soft tissue opacity in the ethmoid region and can identify involvement of the paranasal sinuses or extension across the nasal septum. Computed tomography provides detailed cross-sectional images that precisely delineate the mass boundaries and its relationship to surrounding structures. CT imaging is particularly valuable for surgical planning, helping to determine the optimal approach and anticipate complications. Nuclear scintigraphy can help differentiate ethmoid hematoma from neoplastic masses in some cases.

Differential diagnosis for horses presenting with epistaxis and nasal masses includes several conditions that must be distinguished from progressive ethmoid hematoma. Nasal and sinus neoplasia, including various carcinomas and sarcomas, can present similarly and requires differentiation through histopathology when possible. Fungal infections of the nasal passages and sinuses may cause epistaxis and mass lesions. Dental disease with sinus involvement can produce nasal discharge and facial swelling. Exercise-induced pulmonary hemorrhage causes epistaxis but originates from the lower airways rather than the nasal passages. Trauma-related hemorrhage and foreign bodies are additional considerations. The characteristic endoscopic appearance and location of ethmoid hematoma, combined with imaging findings, usually allows confident diagnosis without biopsy, though histopathologic confirmation may be pursued in atypical cases.

Initial treatment for progressive ethmoid hematoma focuses on accurate assessment of the lesion size and extent to determine the optimal treatment approach. Immediate intervention for acute hemorrhage may include application of cold packs to the nasal area and sedation to reduce blood pressure and anxiety that might exacerbate bleeding. In rare cases of severe epistaxis, temporary nasal packing may be necessary to control bleeding. Once the acute episode has resolved, comprehensive diagnostic evaluation including endoscopy and imaging guides treatment planning. The choice of treatment modality depends on the size, location, and extent of the mass, as well as available facilities and expertise.

Medical management options for progressive ethmoid hematoma include intralesional injection of formalin, which causes tissue necrosis and regression of the mass. This technique involves endoscopic-guided injection of dilute formalin directly into the hematoma, typically requiring multiple treatments spaced several weeks apart. Formalin injection is most successful for small to moderate-sized lesions and offers the advantage of being minimally invasive, performed on standing sedated horses. Success rates vary depending on lesion size, with smaller masses responding more favorably. The technique has fallen somewhat out of favor due to concerns about formalin toxicity and variable success rates, but remains an option for selected cases.

Surgical treatment options provide the most definitive approach for progressive ethmoid hematoma and include several techniques depending on lesion accessibility and surgeon preference. Transendoscopic laser ablation using Nd:YAG or diode lasers can be performed on standing sedated horses for accessible lesions, with the laser energy destroying the hematoma tissue through thermal effects. For larger lesions or those with significant sinus involvement, surgical approaches including frontonasal bone flap, sinus trephination, or transnasal approaches may be required. These procedures are performed under general anesthesia and allow direct visualization and complete removal or ablation of the mass. Success rates for surgical treatment are generally good, particularly when complete lesion removal is achieved.

Supportive care during treatment and recovery includes anti-inflammatory medication to reduce tissue swelling and discomfort. Antimicrobial therapy may be administered prophylactically or to treat secondary infections that occasionally develop within the mass or surgical site. Environmental management emphasizing clean, dust-free conditions helps minimize nasal irritation during healing. Nutritional support ensures adequate intake during recovery, with soft feeds offered if nasal obstruction or discomfort affects eating. Most horses tolerate treatment procedures well and maintain good comfort levels throughout the treatment process.

The rehabilitation period following treatment varies depending on the technique used and the extent of intervention. Horses treated with intralesional injection or laser ablation typically resume normal activities within a few days of each treatment session, with the treatment series spanning several weeks to months. Surgical cases may require several weeks of rest and restricted activity while surgical sites heal. Follow-up endoscopy is essential to monitor response to treatment and detect early signs of recurrence. Most horses can return to normal use once the treatment series is complete and healing has occurred.

Treatment decision factors influencing the approach to progressive ethmoid hematoma include lesion size and location, presence of sinus involvement, available facilities and expertise, cost considerations, and intended use of the horse. Small lesions confined to the ethmoid region may be successfully managed with less invasive techniques including formalin injection or transendoscopic laser. Large lesions with sinus involvement often require surgical approaches for complete treatment. The potential for recurrence exists with all treatment modalities, making long-term monitoring essential regardless of the initial treatment approach. Owner expectations regarding potential recurrence and need for follow-up treatment should be discussed during treatment planning.

Recovery timeline following treatment for progressive ethmoid hematoma varies considerably depending on the treatment modality used and the extent of the original lesion. Horses treated with intralesional formalin injection typically show gradual reduction in mass size over weeks to months, with multiple treatment sessions often required. Laser ablation cases may show more rapid initial response, though complete resolution may still require several weeks. Surgical cases involving bone flap approaches require longer recovery periods of four to eight weeks before returning to normal activities. Resolution of clinical signs, particularly epistaxis, often occurs before complete anatomic resolution of the lesion.

Post-treatment care and monitoring are essential components of successful management of progressive ethmoid hematoma. Follow-up endoscopic examination at regular intervals allows assessment of treatment response and early detection of recurrence. Initial follow-up is typically performed two to four weeks after treatment, with subsequent examinations at one to two month intervals until complete resolution is confirmed. Even after apparent complete resolution, periodic monitoring is recommended due to the significant recurrence potential of this condition. Owners should be instructed to monitor for any return of epistaxis or nasal discharge and report promptly.

Prognosis for progressive ethmoid hematoma is generally favorable for resolution of acute clinical signs, though recurrence represents a significant concern with all treatment modalities. Initial treatment success rates range from sixty to ninety percent depending on the technique used and lesion characteristics. Small lesions diagnosed and treated early generally have better outcomes than large, advanced masses with sinus involvement. Recurrence rates are reported between twenty and forty percent in various studies, with most recurrences developing within the first year after treatment. When recurrence develops, repeat treatment can often be successful, though multiple recurrences may eventually affect long-term prognosis.

Long-term outlook for horses with progressive ethmoid hematoma depends on achieving complete lesion resolution and maintaining vigilance for recurrence. Horses that achieve complete resolution without recurrence can expect return to normal function without long-term complications. Those experiencing recurrence may require multiple treatment courses over time, though most can still be maintained comfortably with appropriate management. In rare cases of extensive, recurrent disease unresponsive to treatment, chronic management of symptoms or consideration of quality of life decisions may become necessary. The generally slow progression of the condition means that even in recurrent cases, horses often maintain reasonable quality of life for extended periods.

Management practices that may help reduce the risk of progressive ethmoid hematoma focus on maintaining optimal respiratory health and minimizing chronic nasal inflammation. Providing horses with clean, well-ventilated housing reduces exposure to dust, mold spores, and other respiratory irritants that can cause chronic nasal inflammation. High-quality forage with minimal dust content supports respiratory health better than poor-quality, moldy, or excessively dusty hay. When hay quality is suboptimal, soaking or steaming before feeding significantly reduces respirable particles and may decrease nasal irritation.

Nutritional factors supporting nasal mucosal health include adequate provision of vitamin A and other nutrients involved in maintaining epithelial integrity. Horses with limited access to fresh forage or those fed primarily processed feeds should receive appropriate supplementation to ensure complete nutrition. Maintaining proper hydration supports normal mucus production and respiratory tract function. While no specific nutritional intervention has been proven to prevent ethmoid hematoma, overall good nutrition contributes to tissue health and may support normal healing responses.

Exercise and conditioning considerations for prevention are limited since progressive ethmoid hematoma does not appear to be associated with exercise intensity or athletic use. However, horses in regular work that develop unexplained epistaxis should be evaluated promptly, as early detection allows treatment when lesions are small and most amenable to therapy. Regular observation of horses during and after exercise provides opportunity to notice any abnormal bleeding or nasal discharge that might indicate developing pathology.

Environmental factors affecting upper respiratory health include stable air quality, bedding choices, and exposure to other horses with respiratory infections. Low-dust bedding options and proper ventilation reduce chronic irritation of the nasal passages. Minimizing exposure to horses with infectious respiratory disease may help prevent the viral and bacterial infections that can cause nasal inflammation. Providing adequate turnout when possible reduces cumulative exposure to stable air contaminants.

General health maintenance and regular veterinary examination provide opportunities for early detection of progressive ethmoid hematoma and other nasal conditions. Annual wellness examinations should include observation of nasal discharge and airflow. Horses with any history of epistaxis should receive endoscopic evaluation to identify or rule out ethmoid hematoma. Since no specific preventive measures are known to reliably prevent this condition, early detection through prompt evaluation of any concerning symptoms represents the best strategy for optimal outcomes.

Daily management adjustments for horses diagnosed with or recovering from progressive ethmoid hematoma emphasize respiratory health and monitoring for recurrence. Feeding practices should prioritize low-dust forage, either through selection of high-quality hay or through soaking or steaming to reduce respirable particles. Feeding from ground level or low feeders encourages natural head position and drainage of any nasal discharge. Monitoring appetite and eating behavior provides early indication of any discomfort or obstruction that might suggest recurrence or complications. Daily observation should include checking for any evidence of epistaxis.

Housing and turnout considerations for horses with a history of progressive ethmoid hematoma focus on air quality and environmental management. Well-ventilated stabling with good air exchange reduces accumulation of dust and respiratory irritants. Low-dust bedding such as paper, cardboard, or dust-extracted shavings is preferable to straw or standard wood shavings. Maximizing turnout time provides the best air quality environment and supports overall respiratory health. When horses must be stabled, ensuring adequate ventilation and minimizing dust exposure helps maintain nasal health.

Exercise modifications during treatment and recovery depend on the specific treatment approach and individual horse response. During active treatment periods, especially following surgical intervention, exercise may be restricted according to veterinary guidance. Once recovery is complete, most horses can return to normal activities without specific exercise limitations. However, ongoing monitoring during exercise for any recurrence of respiratory noise or epistaxis is important. Performance horses should be carefully assessed to ensure complete resolution before returning to competition.

Monitoring and ongoing care requirements for horses with progressive ethmoid hematoma include regular observation for epistaxis, nasal discharge, or respiratory changes that might indicate recurrence. Owners should maintain a log of any bleeding episodes, noting frequency, severity, and which nostril is affected. Scheduled follow-up endoscopic examinations, initially at frequent intervals and eventually annually, allow early detection of recurrence when treatment is most effective. Prompt veterinary consultation for any suspicious symptoms ensures timely intervention if the condition recurs.

Quality of life and use considerations for horses with progressive ethmoid hematoma are generally favorable when appropriate treatment is pursued. Most horses maintain good quality of life throughout treatment and recover to normal function following successful treatment. Athletic use is typically not limited once the condition has resolved, though ongoing monitoring is warranted. The emotional impact on owners of dealing with a condition that may recur should be acknowledged, and realistic expectations regarding the potential need for repeated treatment should be established. With appropriate management, most horses with this condition enjoy comfortable, functional lives.

No specific breed has been definitively established as being at higher risk for progressive ethmoid hematoma, though some studies have suggested slightly increased incidence in certain breeds. Thoroughbreds, Arabians, and Warmbloods appear in some reports with higher frequency, though this may reflect the intensive veterinary monitoring and performance expectations in these breeds rather than true genetic predisposition. The condition has been documented across essentially all horse breeds, as well as in ponies and donkeys, without clear breed-specific patterns. Age represents a much stronger risk factor than breed, with the vast majority of cases occurring in horses over nine years of age.

Discipline and use factors do not appear to significantly influence the development of progressive ethmoid hematoma, unlike some other upper respiratory conditions that are more common in specific athletic populations. Horses in all disciplines from pleasure riding to racing may develop the condition with similar likelihood. However, horses in active training and competition may be more likely to have the condition diagnosed early due to more frequent veterinary contact and closer attention to any performance changes. Retired horses or those in light use may have lesions go undetected longer if epistaxis episodes are mild or not observed.

Genetic testing for progressive ethmoid hematoma is not available, as no heritable genetic factors have been identified. The condition appears to develop sporadically without familial clustering that would suggest genetic transmission. Breeding decisions for horses that have had progressive ethmoid hematoma need not be specifically influenced by the condition, as there is no evidence of hereditary transmission. The age of onset, typically in middle-aged to older horses, means that affected horses have often already had breeding careers before developing the condition. Overall, breed and genetic considerations play minimal roles in the risk assessment for this condition.

Commonly co-occurring conditions with progressive ethmoid hematoma include paranasal sinus involvement that develops as the expanding mass extends beyond the nasal passages. Secondary sinusitis may develop from obstruction of normal sinus drainage or from infection within the hematoma itself. Dental disease of the upper cheek teeth may coexist and should be evaluated, as both conditions can cause facial swelling and nasal discharge. Some horses with progressive ethmoid hematoma have concurrent fungal infections of the nasal passages or guttural pouches, though whether this represents coincidental occurrence or a causative relationship is unclear.

Conditions with similar symptoms that must be differentiated from progressive ethmoid hematoma include primary nasal and sinus neoplasia, which can present with nearly identical clinical signs of epistaxis and nasal obstruction. Sinonasal carcinomas, squamous cell carcinomas, and other malignant tumors require differentiation through imaging characteristics and sometimes histopathology. Mycotic infections of the nasal passages and guttural pouches can cause epistaxis and mass-like lesions. Exercise-induced pulmonary hemorrhage causes epistaxis but originates from the lungs rather than the nasal passages. Traumatic causes of epistaxis including skull fractures and foreign body penetration must be considered. Coagulation disorders causing generalized bleeding tendency should be ruled out in horses with unexplained epistaxis.

Potential complications of progressive ethmoid hematoma include severe hemorrhage that may occasionally cause significant blood loss requiring transfusion in rare cases. Extension of the mass into the paranasal sinuses can lead to chronic sinusitis that may persist even after the primary lesion is treated. Bone involvement and facial deformity may develop in advanced cases and may not completely resolve even with successful treatment of the hematoma. Secondary bacterial infection of the mass or surgical sites can occur. The most significant long-term complication is recurrence of the condition, which occurs in a substantial percentage of cases and may require repeated treatment over time.